A brand novel era of drugmaker affect: How the pandemic inspired pharma entrepreneurs to purpose medical doctors in novel ways
When a novel prostate cancer therapy is well-liked by the Food and Drug Administration, it’s especially pertinent to a small neighborhood of oncologists. And for the final half-century or so, drug corporations left it as much as reps to keep…